CD4 and Hodgkins lymphoma: We found additional predictors of survival in the HIV-HL cohort include CD4 count levels, HAART use, and the duration of HAART use.Both the use of HAART and the duration of use for more than ten months led to significant improvements in survival (P = 0.000).In Spain, patients on HAART were found to have significantly higher OS and DFS than non-HAART patients [26].